Paraoxonase-1 polymorphisms and cerebral ischemic stroke: a pilot study in mexican patients

Fuente: Redalyc
Saved in:
Bibliographic Details
Main Author: María Fernanda Martínez-Salazar
Format: Artículo científico
Language:en
Published: Universidad del Valle 2018
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1876466940772352000
author María Fernanda Martínez-Salazar
author_facet María Fernanda Martínez-Salazar
contents Paraoxonase-1 polymorphisms and cerebral ischemic stroke: a pilot study in mexican patients María Fernanda Martínez-Salazar María de la Luz Soriano-Martínez Alina Juantorena-Ugas Damianys Almenares-López Petra Yescas Marie-Catherine Boll Antonio Monroy-Noyola Medicina stroke arylesterase Atherosclerosis aryldialkylphosphatase carboxylic ester hydrolases Background: The serum paraoxonase-1 (PON1) associated to HDL presents two common polymorphisms in the positions 192 and 55. These polymorphisms are considered determinant of the capacity of HDL to protect LDL from their oxidative modification. In this context, the PON1 genotype has been associated with cardiovascular diseases, including stroke.Objective: To determine the allelic and genotypic frequencies of PON1 L55M and Q192R as well as the enzymatic activities of PON1 in subjects with and without atherothrombotic stroke.Methods: There were included 28 people with atherothrombotic stroke and 29 without stroke. The genotyping was carried out by PCR-RFLP and the phenotyping by measurement of the activities of paraoxonase and arylesterase in serum.Results: For the polymorphism Q192R, the allelic frequencies (Q/R) were 0.46/0.54 and 0.48/0.52 (p= 0.843) for the control group and the group with stroke, respectively. While for the polymorphism L55M, the allelic frequencies (L/M) were 0.81/0.19 for the control group, and 0.78/0.22 for the group with stroke (p= 0.610). The activity levels of paraoxonase were not significantly different between the control and stroke groups (450 vs. 348 UI/mL, p= 0.093) While the activity levels of arylesterase were significantly different between the studied groups (90 vs. 70 UI/mL, p= 0.001); however, upon adjustment by multiple linear regression, it was not longer significant.Conclusion: The polymorphisms Q192R and L55M, and the paraoxonase activity of PON1 are not risk factors for atherothrombotic stroke according to the results of this study. 2018 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28357492006 https://www.redalyc.org/journal/283/28357492006/ https://www.redalyc.org/journal/283/28357492006/html/ https://www.redalyc.org/journal/283/28357492006/28357492006.epub https://www.redalyc.org/journal/283/28357492006/movil 10.25100/cm.v49i2.2217 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.3 Vol.49
format Artículo científico
id redalyc_28357492006
institution Redalyc
language en
publishDate 2018
publisher Universidad del Valle
spellingShingle Paraoxonase-1 polymorphisms and cerebral ischemic stroke: a pilot study in mexican patients
María Fernanda Martínez-Salazar
Medicina
stroke
arylesterase
Atherosclerosis
aryldialkylphosphatase
carboxylic ester hydrolases
Paraoxonase-1 polymorphisms and cerebral ischemic stroke: a pilot study in mexican patients María Fernanda Martínez-Salazar María de la Luz Soriano-Martínez Alina Juantorena-Ugas Damianys Almenares-López Petra Yescas Marie-Catherine Boll Antonio Monroy-Noyola Medicina stroke arylesterase Atherosclerosis aryldialkylphosphatase carboxylic ester hydrolases Background: The serum paraoxonase-1 (PON1) associated to HDL presents two common polymorphisms in the positions 192 and 55. These polymorphisms are considered determinant of the capacity of HDL to protect LDL from their oxidative modification. In this context, the PON1 genotype has been associated with cardiovascular diseases, including stroke.Objective: To determine the allelic and genotypic frequencies of PON1 L55M and Q192R as well as the enzymatic activities of PON1 in subjects with and without atherothrombotic stroke.Methods: There were included 28 people with atherothrombotic stroke and 29 without stroke. The genotyping was carried out by PCR-RFLP and the phenotyping by measurement of the activities of paraoxonase and arylesterase in serum.Results: For the polymorphism Q192R, the allelic frequencies (Q/R) were 0.46/0.54 and 0.48/0.52 (p= 0.843) for the control group and the group with stroke, respectively. While for the polymorphism L55M, the allelic frequencies (L/M) were 0.81/0.19 for the control group, and 0.78/0.22 for the group with stroke (p= 0.610). The activity levels of paraoxonase were not significantly different between the control and stroke groups (450 vs. 348 UI/mL, p= 0.093) While the activity levels of arylesterase were significantly different between the studied groups (90 vs. 70 UI/mL, p= 0.001); however, upon adjustment by multiple linear regression, it was not longer significant.Conclusion: The polymorphisms Q192R and L55M, and the paraoxonase activity of PON1 are not risk factors for atherothrombotic stroke according to the results of this study. 2018 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28357492006 https://www.redalyc.org/journal/283/28357492006/ https://www.redalyc.org/journal/283/28357492006/html/ https://www.redalyc.org/journal/283/28357492006/28357492006.epub https://www.redalyc.org/journal/283/28357492006/movil 10.25100/cm.v49i2.2217 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.3 Vol.49
title Paraoxonase-1 polymorphisms and cerebral ischemic stroke: a pilot study in mexican patients
topic Medicina
stroke
arylesterase
Atherosclerosis
aryldialkylphosphatase
carboxylic ester hydrolases
url https://www.redalyc.org/articulo.oa?id=28357492006
https://www.redalyc.org/journal/283/28357492006/
https://www.redalyc.org/journal/283/28357492006/html/
https://www.redalyc.org/journal/283/28357492006/28357492006.epub
https://www.redalyc.org/journal/283/28357492006/movil